Farmaseutikal: Major
Syarikat Syarikat-syarikat Argentina beroperasi dalam satu industri:farmaseutikal: major
Senarai di bawah mempunyai Syarikat-syarikat Argentina yang beroperasi di bawah industri yang sama, farmaseutikal: major. Senarai ini membantu menjejak prestasi, penyata pendapatan mereka dan banyak lagi. Disusun dengan menggunakan mana-mana metrik yang sesuai, ia boleh menunjukkan saham paling mahal dalam industri seperti ASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25 atau yang mempunyai dinamik harga terbaik seperti ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD), menjadikannya berguna dalam membantu mencipta strategi untuk apa-apa sasaran.
Simbol | Permodalan Pasaran | Harga | Perubahan % | Volum | Vol Relatif | P/E | EPS cair TTM | Pertumbuhan EPS cair TTM YoY | Hasil dividen % TTM | Sektor | Penarafan Penganalisa |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYELI LILLY AND COMPANY CEDEAR EACH 56 REP 1DR | 620.701 T ARS | 14250.000 ARS | −0.74% | 2.467 K | 1.15 | — | — | — | — | Teknologi Kesihatan | — |
| LLYDELI LILLY AND COMPANY CEDEAR EACH 56 REP 1 (USD) DR | 620.701 T ARS | 14.000 USD | +3.70% | 65 | 0.74 | — | — | — | — | Teknologi Kesihatan | — |
 DJN3BJOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS)DR | 303.36 T ARS | 1147.500 ARS | +0.48% | 1 M | 2.65 | — | — | — | — | Teknologi Kesihatan | — |
| JNJ.BJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 303.36 T ARS | 10500.000 ARS | −20.99% | 2.511 K | 0.07 | 87.45 | 120.07 ARS | +108.91% | 0.89% | Teknologi Kesihatan | — |
| DJNJ3JOHNSON & JOHNSON CEDEAR(REPR 6.95% BDS) DR | 303.36 T ARS | 1197.000 ARS | −1.89% | 4 | 0.00 | — | — | — | — | Teknologi Kesihatan | — |
| JNJJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS DR | 303.36 T ARS | 10242.500 ARS | −1.41% | 9.531 K | 0.36 | 85.30 | 120.07 ARS | +108.91% | 0.89% | Teknologi Kesihatan | — |
| JNJDJOHNSON & JOHNSON CEDEAR EACH 15 REP 1 ORD SHS(USD) DR | 303.36 T ARS | 10.100 USD | −0.98% | 1.42 K | 1.71 | 68.00 | 120.07 ARS | −50.87% | 0.89% | Teknologi Kesihatan | — |
 MRKMERCK & CO INC CEDEAR (5 REP 1 USD0.50)DR | 276.102 T ARS | 26571.000 ARS | −1.12% | 967 | 1.50 | — | — | — | — | Teknologi Kesihatan | — |
| MRKDMERCK & CO INC CEDEAR EAC 5 RE 1 (USD) DR | 276.102 T ARS | 26.000 USD | 0.00% | 20 | 4.08 | — | — | — | — | Teknologi Kesihatan | — |
 ABBVABBVIE INC CEDEAR EACH 10 REPR 1 COMDR | 252.895 T ARS | 17441.000 ARS | −0.17% | 11.462 K | 9.17 | 21.73 | 802.79 ARS | −6.12% | 1.01% | Teknologi Kesihatan | — |
| ABBVDABBVIE INC CEDEAR EA 10 REP 1 COM(USD) DR | 252.895 T ARS | 17.700 USD | −5.85% | 49 | 0.42 | 17.82 | 802.79 ARS | −77.92% | 1.01% | Teknologi Kesihatan | — |
 AZNASTRAZENECA CEDEAR EACH REP 0.5 ADR USD0.25DR | 182.355 T ARS | 36516.000 ARS | −0.64% | 54 | 0.09 | 175.58 | 207.98 ARS | +257.80% | 1.16% | Teknologi Kesihatan | — |
| AZNDASTRAZENECA CEDEAR EA RE 0.5 ADR (USD) DR | 182.355 T ARS | 36.750 USD | −0.27% | 5 | 0.70 | 142.85 | 207.98 ARS | −15.86% | 1.16% | Teknologi Kesihatan | — |
 NVSNOVARTIS AG CEDEAR EACH 4 REP 1DR | 160.312 T ARS | 24670.000 ARS | −1.71% | 5 | 0.07 | — | — | — | — | Teknologi Kesihatan | — |
| NVSDNOVARTIS AG CEDEAR EAC 4 REP 1(USD) DR | 160.312 T ARS | 23.100 USD | −3.95% | 6 | 1.03 | — | — | — | — | Teknologi Kesihatan | — |
 PFEPFIZER INC CEDEAR EACH 4 REP 1 ORD USD0.05DR | 124.818 T ARS | 6759.000 ARS | −2.20% | 13.482 K | 0.57 | — | — | — | — | Teknologi Kesihatan | — |
| PFEDPFIZER INC CEDEAR 4 REP 1 ORD USD0.05(USD) DR | 124.818 T ARS | 6.580 USD | −3.24% | 510 | 0.58 | — | — | — | — | Teknologi Kesihatan | — |
 AMGNAMGEN INC CEDEAR EACH 30 REP 1DR | 123.061 T ARS | 9379.500 ARS | −1.41% | 461 | 0.22 | — | — | — | — | Teknologi Kesihatan | — |
| AMGNDAMGEN INC CEDEAR EACH 30REPR 1 ORD USD0.0001 (USD) DR | 123.061 T ARS | 9.400 USD | −3.59% | 4 | 0.08 | — | — | — | — | Teknologi Kesihatan | — |
 BMYBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1DR | 84.313 T ARS | 17007.500 ARS | −2.05% | 149 | 0.40 | — | — | — | — | Teknologi Kesihatan | — |
| BMYDBRISTOL-MYERS SQUIBB CO CEDEAR EACH 3 REP 1 DR | 84.313 T ARS | 17.500 USD | +2.04% | 6 | — | — | — | — | — | Teknologi Kesihatan | — |
 GSKGSK PLC CEDEAR EACH REPR 1/4 ADRDR | 70.961 T ARS | 10567.000 ARS | −1.59% | 179 | 0.67 | 54.38 | 194.30 ARS | −31.41% | 1.40% | Teknologi Kesihatan | — |
| GSKDGSK PLC CEDEAR EACH REPR 1/4 ADR (USD) DR | 70.961 T ARS | 10.200 USD | −8.52% | 100 | 5.21 | 42.44 | 194.30 ARS | −83.87% | 1.40% | Teknologi Kesihatan | — |
 BIIBBIOGEN INC CEDEAR EACH 13 REP 1 COM USD0.0005DR | 24.289 T ARS | 15750.000 ARS | −2.88% | 495 | 1.14 | — | — | — | — | Teknologi Kesihatan | — |
| BIIBDBIOGEN INC CEDEAR EAC 13 RE 1 COM(USD) DR | 24.289 T ARS | 20.000 USD | +2.04% | 18 | 2.69 | — | — | — | — | Teknologi Kesihatan | — |
 RICHLABORATORIOS RICHMOND SACIF | 72.676 B ARS | 900.000 ARS | +1.12% | 1.438 K | 0.15 | — | −130.78 ARS | — | 0.00% | Teknologi Kesihatan | — |
 ROSEINSTITUTO ROSENBUCH SA DE BIOLOGIA | 4.344 B ARS | 102.000 ARS | −0.97% | 1.159 K | 0.18 | — | — | — | 0.00% | Teknologi Kesihatan | — |